Company Overview and News

 
MEG Starts Bidding War After Rejecting $2.34B Husky Offer

2018-10-17 rigzone
(Bloomberg) -- MEG Energy Corp. rejected a C$3.05 billion ($2.34 billion) hostile takeover offer from Husky Energy Inc. and announced a plan to seek other buyers, kicking off a bidding war for its prized Canadian oil-sands assets.
HSE IMO CNQ MEG MEGEF HUSKF IMO SU SU

108
WCS And Edmonton Mixed Sweet Discounts To WTI: Darkest Before Dawn

2018-10-16 seekingalpha - 2
Activism in Canada is largely responsible for transportation constraints such as pipeline bottlenecks, hurting the Canadian economy in ways that Canadians could never imagine.
BTE CVE CRLFF CEI TOT ENB IMO CNI ZPTAF CHAP RRENF SNZYP TDG SN TRP IMO MEG HKRCP BP VET CVE BTE ECR USEG CHPE CP USO IKM CJ GST-A GST-B GST PTOAF WCP SCAZP HUSKF AXAS PTOAD SGY VET SPE TECK HSE AREX TDGCF CP ROSEU REI AMR MEGEF IPCFF TCKRF RRX ROSE PDS PRCYF RZREF HK SPGYF PTORF

 
Share buybacks have hit record levels. Here’s what it means for investors

2018-10-12 thestar
This copy is for your personal non-commercial use only. To order presentation-ready copies of Toronto Star content for distribution to colleagues, clients or customers, or inquire about permissions/licensing, please go to: www.TorontoStarReprints.com
RCIAF CDNTF IMO RCI CDNAF CIX CIFAF IMO SU SU

9
M&A Updates: Patience Is The Key For Digirad/Aetrium Deal

2018-10-05 seekingalpha - 1
Take a look at Digirad/ATRM deal, which I’ve also added to my followed deals. It is a super small transaction as ATRM’s market cap is only $1.3m (as at October 4), so it is surprising that it is a public company in the first place. Both stocks are illiquid, however I believe a nice position can be obtained.
IMO MEG HUSKF IMO SU HSE BOJA CNQ MEGEF ATRM FMBI CI DRAD AET SU

 
Northwest Territories premier believes talks to manage offshore Arctic drilling may signal end of ban

2018-10-05 globalnews.ca
This Jan. 7, 2013, file photo, shows the Shell floating drill rig Kulluk in Kodiak Island, Alaska's Kiliuda Bay.
IMO IMO

7
Clogged pipelines cut Canada's oil price, small producers shift strategy

2018-10-04 reuters
WINNIPEG, Manitoba (Reuters) - Small Canadian oil producers are striking complex deals with refineries, diversifying production and seeking marketing help as they try to soften the blow from record price discounts on heavy crude generated by pipeline congestion.
PGH IMO GXE GENGF ATHOF IMO ATH PGHEF SU SU

 
Hearing for Alberta oilsands project cancelled after First Nation strikes deal with Imperial Oil

2018-10-02 globalnews.ca
The Alberta Energy Regulator says it is no longer considering holding a public hearing for a new oilsands project after an Indigenous community reached a deal with the proponent. An aerial view of Fort McKay, Alta., Monday, Sept. 19, 2011.
IMO IMO

 
Aspen oilsands project hearing cancelled after First Nation strikes deal with Imperial

2018-10-02 cbc.ca
The Alberta Energy Regulator says it's no longer considering holding a public hearing for a new oilsands project after an Indigenous community reached a deal with the proponent, Imperial Oil.
IMO IMO

 
Big 4 in the oilsands could soon become the Big 5

2018-10-02 cbc.ca
Husky Energy has ambitions to grow but instead of building a new, multi-billion-dollar facility in the Alberta oilsands, the Calgary-based company is launching a hostile takeover of MEG Energy.
HSE IMO CNQ MEG MEGEF HUSKF IMO COSWF

 
MEG Energy shares soar on Husky offer

2018-10-01 thestar
This copy is for your personal non-commercial use only. To order presentation-ready copies of Toronto Star content for distribution to colleagues, clients or customers, or inquire about permissions/licensing, please go to: www.TorontoStarReprints.com
HSE IMO MEG MEGEF HUSKF IMO SU SU COSWF

 
Shares in MEG soar as analysts predict Husky will boost hostile takeover offer

2018-10-01 cbc.ca
Financial analysts say Husky Energy Inc. will likely have to sweeten its $3.3-billion hostile takeover bid for fellow Calgary oilsands producer MEG Energy Corp., although they concede there are few white knights that are big enough to ride to its rescue.
HSE IMO MEG MEGEF HUSKF IMO SU SU COSWF

 
Husky sees MEG as potential 'hand-in-glove' Canada oil sands merger

2018-10-01 channelnewsasia
Husky Energy Inc's hostile bid for MEG Energy Corp reflects the need for Canadian oil companies to own integrated assets, from production to refineries, to manage the deep price discounts on Canadian crude, Husky's chief executive said on Monday.
HSE IMO MEG MEGEF HUSKF IMO CEO SU SU

2
CANADA STOCKS-TSX at three-month low as trade worries weigh

2018-09-11 reuters
Sept 11 (Reuters) - Canada’s main stock index touched over three-month lows on Tuesday led by declines in materials companies amid the ongoing Sino-U.S. trade dispute and uncertainty over the future of NAFTA trade pact.
FR OMI IMO ABX OMI ACBFF NPIFF IMO SU NPI OROXF RNX RNX.WT ACB RNKLF CNQ BRPIF FQVLF AG FQM ABX SU

41
Sector Allocations

2018-09-03 seekingalpha - 2
This is a follow-up to my August 20, 2018 article, which included a portfolio review, but not sector information. (Note to non-PRO subscribers: I've avoided writing single ticker articles to prevent them from being paywalled, but SA made the dual-ticker August 20 article an Editor's Pick and paywalled it. C'est la vie.)
SOJA VT TXN RDSB RDSA IMO AAPL DOV GSK RYDAF INTC ORCL LEG SO DUKH IMO RDS.B GEC GE RDS.A DUK GSK MFC BLK TGT 0945 CVX RYDBF GNE MFC MSFT OXY

 
IMO / Imperial Oil Ltd. 8-K (Current Report)

2018-08-29 sec.gov
8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURREN
IMO

Related Articles

ALIM: Alimera Sciences Analysis and Research Report

2018-10-01 - Asif

Overview The following discussion and analysis should be read in conjunction with its unaudited interim condensed consolidated financial statements and the related notes that appear elsewhere in this quarterly report on Form 10-Q. This discussion contains forward-looking statements reflecting its current expectations that involve risks and uncertainties. Actual results may differ materially from those discussed in these forward-looking statements due to a number of factors, including those set forth in the section entitled “Risk Factors” in its most recent annual report on Form 10-K. For further information regarding forward-looking statements, please refer to the “Special Note Regarding Forward-Looking Statements and Projections” immediately after the index to this quarterly report on Form 10-Q. Alimera Sciences, Inc., and its subsidiaries (we or Alimera), is a pharmaceutical company that specializes in the commercialization and development of prescription ophthalmic pharma...

DMPI: DelMar Pharmaceuticals Analysis and Research Report

2018-09-25 - Asif

Background DelMar Pharmaceuticals, Inc. is a clinical stage drug development company with a focus on the treatment of cancer. The company's mission is to benefit patients and create shareholder value by developing and commercializing anti-cancer therapies for patients whose tumors exhibit features that make them resistant to, or unlikely to respond to, currently available therapies, particularly for orphan cancer indications where patients have failed, or are unlikely to respond to, currently available therapy. DelMar Pharmaceuticals is developing VAL-083, a novel, DNA-targeting agent, for the treatment of glioblastoma multiforme (“GBM”) and potentially other solid tumors, including ovarian cancer. VAL-083 is a first-in-class, DNA-targeting chemotherapeutic that demonstrated activity against a range of tumor types in prior Phase 1 and Phase 2 clinical studies sponsored by the US National Cancer Institute (“NCI”). The company's recent research has highlighted the opportunit...

RIGL: Rigel Pharmaceuticals Analysis and Research Report

2018-09-18 - Asif

Overview Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. The company's pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company's first FDA-approved product is TAVALISSE™ (fostamatinib disodium hexahydrate), an oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The company's current clinical programs include Phase 2 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy, and a Phase 1 study for its IRAK program. In addition, Rigel Pharmaceuticals has product candidates in development with partners BerGenBio AS, Daiichi Sankyo, and Aclaris Therapeutics. Since inception, Rigel Pharmaceuticals h...

Silicon Investor Message Boards

This table lists all message boards related to IMO / Imperial Oil Ltd. on message board site Silicon Investor.

Silicon Motion Inc. (SIMO) Silicon Motion Inc. (SIMO) Silicon Motion Inc. (SIMO) SIMO Busters SIMO Busters SIMO Busters
Simon Property Group, Inc. (SPG) Simon Property Group, Inc. (SPG) Simon Property Group, Inc. (SPG) Imogo Mobile Technologies Corp. Imogo Mobile Technologies Corp. Imogo Mobile Technologies Corp.
PIMO, any thoughts on the stock movements? PIMO, any thoughts on the stock movements? PIMO, any thoughts on the stock movements? Timothy McVeigh Timothy McVeigh Timothy McVeigh
PIMO Recently Signed another Auto-DR Contract PIMO Recently Signed another Auto-DR Contract PIMO Recently Signed another Auto-DR Contract PIMO has one of the most impressive BOD���s for a micro cap PIMO has one of the most impressive BOD���s for a micro cap PIMO has one of the most impressive BOD���s for a micro cap
PIMO Provides Shareholder Update PIMO Provides Shareholder Update PIMO Provides Shareholder Update PIMO Energy Division Secures Another Contract PIMO Energy Division Secures Another Contract PIMO Energy Division Secures Another Contract
CUSIP: 453038408